Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 121.58 -0.01 (-0.01%) Market Cap: 7.35 Bil Enterprise Value: 10.93 Bil PE Ratio: 17.12 PB Ratio: 1.76 GF Score: 85/100

Jazz Pharmaceuticals PLC at Cowen Healthcare Conference (Virtual) Transcript

Mar 02, 2021 / 05:50PM GMT
Release Date Price: $165.75 (-1.81%)
Kenneth Charles Cacciatore
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Great. Thanks, everyone, for joining us. Thanks, Bruce and Justin and Robert and Kim. We really appreciate you taking the time with us this afternoon. I'm joined by Stacy and Georgi as well.

Bruce, like a lot of things, I usually tend to go on many ramps when I introduce the companies. And in your case, I have a little bit of a story. But the story, I think, will make sense. It was the morning that the announcement was made about GW. And of course, Phil Nadeau, my dear friend and colleague, covers GW. And we usually sit right next to each other in the office and could be in each other's office very quickly. But I had to ask, "Phil, can you send me your model?" And he had a busy morning as well. And so we weren't able to communicate. I got his model, and I had one of those uh-oh moments. "Uh-oh, Phil's got this asset, great asset, Epidiolex, going generic in 2026." And I don't have him right there, able to grab him and say, "Phil, what's going on here?" But -- so very quickly, and a lot of e

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot